Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chinghai Kao

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Gene Medicine|September 2, 2003
Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirusJin Zhong Li, Gerald R Hankins, Chinghai Kao, et al.
Urology|March 19, 2004
Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancerToshiro Shirakawa, Akinobu Gotoh, Zhujun Zhang, et al.
Anticancer Research|August 28, 2004
Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer modelLiang Cheng, Shaobo Zhang, Christopher J Sweeney, et al.
Immunology|April 2, 2011
The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasisCatherine E Steding, Sung-tse Wu, Yanping Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacyXiong Li, You-Hong Liu, Sang-Jin Lee, et al.
Anticancer Research|December 12, 2003
Expression of osteocalcin in prostate cancer before and after hormonal therapyYen-Chuan Ou, Jung-Ta Chen, Chi-Rei Yang, et al.
The Prostate|May 3, 2002
Relative promoter strengths in four human prostate cancer cell lines evaluated by particle bombardment-mediated gene transferShaobo Zhang, Jian Gu, Ning-Sun Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor modelSudhanshu P Raikwar, Constance J Temm, Nandita S Raikwar, et al.
Oncotarget|January 22, 2015
Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cellsYouhong Liu, Lin Chen, Zhicheng Gong, et al.
Human Gene Therapy|May 30, 2008
Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapyMatthew J Mellon, Kyung-Hee Bae, Catherine E Steding, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Gene Medicine|September 2, 2003
Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirusJin Zhong Li, Gerald R Hankins, Chinghai Kao, et al.
Urology|March 19, 2004
Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancerToshiro Shirakawa, Akinobu Gotoh, Zhujun Zhang, et al.
Anticancer Research|August 28, 2004
Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer modelLiang Cheng, Shaobo Zhang, Christopher J Sweeney, et al.
Immunology|April 2, 2011
The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasisCatherine E Steding, Sung-tse Wu, Yanping Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacyXiong Li, You-Hong Liu, Sang-Jin Lee, et al.
Anticancer Research|December 12, 2003
Expression of osteocalcin in prostate cancer before and after hormonal therapyYen-Chuan Ou, Jung-Ta Chen, Chi-Rei Yang, et al.
The Prostate|May 3, 2002
Relative promoter strengths in four human prostate cancer cell lines evaluated by particle bombardment-mediated gene transferShaobo Zhang, Jian Gu, Ning-Sun Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor modelSudhanshu P Raikwar, Constance J Temm, Nandita S Raikwar, et al.
Oncotarget|January 22, 2015
Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cellsYouhong Liu, Lin Chen, Zhicheng Gong, et al.
Human Gene Therapy|May 30, 2008
Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapyMatthew J Mellon, Kyung-Hee Bae, Catherine E Steding, et al.
Pageof 5